Key Word(s): 1. gastric
cancer; 2. serum proteomics; 3. iTRAQ; 4. D-LC-MS/MS; Presenting Author: MALU JUN Additional Authors: LINYAO GUANG Corresponding Author: LINYAO GUANG Affiliations: guangxi medical university Objective: To study the expression of S100A11 and Beclin1 in gastric carcinoma, precancerous lesion and chronic nonatrophic pangastritis, and the relationship between S100A11 and Beclin1 expression in gastric cancerous tissues and the biological behaviour of gastric carcinoma, investigate the mechanism and clinical significance of S100A11 and Beclin1 Doxorubicin in the development of gastric carcinoma. Methods: The expression of S100A11 and Beclin1 proteins were determined by streptavidin-perosidase immunohistochemical method in 50 cases of gastric carcinoma from exairesis tissues, 30 cases of precancerous lesion and 20 cases of chronic nonatrophic pangastritis from endoscopic biopsy. Pathological image analysis system be used to analysis the grey level of S100A11 and Beclin1, then analyze the mechanism and clinical significance of S100A11 and Beclin1 in the development of gastric carcinoma.
Results: The positive expression grey level of S100A11 in gastric carcinoma was 132.9209 ± 5.649, and in precancerous lesion tissues was 133.6706 ± 5.8348, both of them were significantly lower than that of in chronic nonatrophic Montelukast Sodium pangastritis tissues (138.048 ± 3.5902), ICG-001 in vivo There were significant difference between the gastric carcinoma and chronic nonatrophic pangastritis tissues, precancerous lesion tissues and chronic nonatrophic pangastritis tissues (P < 0.05), But there was no difference between the gastric carcinoma and precancerous lesion tissues (P > 0.05). There was obvious correlation between the expression of S100A11 and the clinicopathological
factors, such as grading, infiltrating depth, lymph nodes metastasis, TNM degree (P < 0.05), but there was no correlation between the expression of S100A11 and position, knubbly diameter (P > 0.05). The positive expression grey level of Beclin1 in gastric carcinoma was 140.9705 ± 6.2019, which was significantly higher than those in precancerous lesion tissues (136.711 ± 5.5759) and in chronic nonatrophic pangastritis tissues (130.8024 ± 2.5363), there were significantly differences between two of the three tissues (P < 0.05). There was correlation between the expression of Beclin1 and grading, lymph nodes metastasis (P < 0.05), but there was no correlation between the expression of Beclin1 and position, diameter, infiltrating depth, TNM degree (P > 0.05), There existed a negative correlation between S100A11 and Beclin1 in gastric carcinoma (r = −0.156, P < 0.05).